JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells

EZH1 Mediates Methylation on Histone H3 Lysine 27 and Complements EZH2 in Maintaining Stem Cell Identity and Executing Pluripotency

Xiaohua Shen, Yingchun Liu, Yu-Jung Hsu et al. · Molecular Cell · 2008 · 1K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-<i>cis</i>-Retinoic Acid: A Children's Oncology Group Study

Katherine K. Matthay, C. Patrick Reynolds, Robert C. Seeger et al. · Journal of Clinical Oncology · 2009 · 856 citations

Medicine, Oncology, Chemotherapy +6

<i>PAX3-FKHR</i> and <i>PAX7-FKHR</i> Gene Fusions Are Prognostic Indicators in Alveolar Rhabdomyosarcoma: A Report From the Children’s Oncology Group

Poul H. Sorensen, James C. Lynch, Stephen J. Qualman et al. · Journal of Clinical Oncology · 2002 · 741 citations

Medicine, Genetics, Oncology +17

JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells

Diego Pasini, Paul A. Cloos, Julian Walfridsson et al. · Nature · 2010 · 571 citations

Life Sciences, Genetics, Molecular Biology +10

Jarid2/Jumonji Coordinates Control of PRC2 Enzymatic Activity and Target Gene Occupancy in Pluripotent Cells

Jamy C. Peng, Anton Valouev, Tomek Swigut et al. · Cell · 2009 · 537 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15